Wells Fargo raised the firm’s price target on Oscar Health (OSCR) to $14 from $10 and keeps an Underweight rating on the shares. The firm is updating estimates and price targets in the space ahead of Q3 2025 results. Notability, Wells now assumes extension of enhanced subsidies is likely.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Moderately bullish activity in Oscar Health with shares down 2.77%
- Oscar Health Issues $410M Convertible Notes for Growth
- Moderately bullish activity in Oscar Health with shares up 7.4%
- Oscar Health Announces $355M Convertible Notes Offering
- Closing Bell Movers: Dave & Buster’s slumps 16% on Q2 miss